Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting cancer’s sweet spot: UGP2 as a therapeutic vulnerability

Published:2021-10-27 Issue:6 Volume:8 Page:
ISSN:2372-3556
Container-title:Molecular & Cellular Oncology
language:en
Short-container-title:Molecular & Cellular Oncology

Author:

Kim Sunghoon¹²^ORCID,Wolfe Andrew³⁴^ORCID,Kim Sung Eun¹²^ORCID

Affiliation:

1. Department of Biosystems and Biomedical Sciences, College of Health Sciences, Korea University, Seoul, Republic of Korea

2. Department of Integrated Biomedical and Life Sciences, College of Health Sciences, Korea University, Seoul, Republic of Korea

3. Department of Biological Sciences, Hunter College of the City University of New York, New York, NY, USA

4. Departments of Biology and Biochemistry, The Graduate Center of the City University of New York, New York, NY, USA

Funder

Damon Runyon Cancer Research Foundation

National Cancer Institute of the NIH

the National Research Foundation of Korea

Publisher

Informa UK Limited

Subject

Cancer Research,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/23723556.2021.1990676

Reference10 articles.

1. Demonstration, by renaturation in O'Farrell gels, of heterogeneity in Dictyostelium uridine diphosphoglucose pyrophosphorylase

2. A Quaternary Mechanism Enables the Complex Biological Functions of Octameric Human UDP-glucose Pyrophosphorylase, a Key Enzyme in Cell Metabolism

3. UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth

4. Coordinate Regulation of Sugar Flux and Translation by PAS Kinase

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the redox-active MnTnHex-2-PyP5+ and cisplatin on the metabolome of non-small cell lung cancer cells;Biochemical Pharmacology;2024-09

2. Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function;2024-07-16

3. KRAS: Biology, Inhibition, and Mechanisms of Inhibitor Resistance;Current Oncology;2024-04-03

4. Evaluating Cross-modal Generative Models Using Retrieval Task;Proceedings of the 46th International ACM SIGIR Conference on Research and Development in Information Retrieval;2023-07-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3